Trialsglp-1 receptor agonistsbody compositionsarcopeniaclinicaltrials.gov

Mexican cohort to track muscle loss in 168 adults starting GLP-1 agonists

The observational study uses DXA scans plus grip strength and walking speed over 52 weeks, with no randomization or study drug.

By Priya Raman · Science Reporter

Sep 25 08:00 ETSource: ClinicalTrials.gov

The wire

01NCT07835360, sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, began recruiting July 10, 2026, enrolling about 168 adults at two Mexican centers.
02Participants get DXA body composition, grip strength and gait speed testing at baseline, 24 and 52 weeks, addressing clinician questions about lean mass loss on incretin therapy.
03It is observational with no placebo or randomization, so results will be subject to confounding by prescriber choice, diet and activity.

From the source

Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes
NCT07835360 · N/A · RECRUITING · Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Conditions: Obesity (Disorder), Type 2 Diabetes Mellitus.

Read at clinicaltrials.gov

Source URL https://clinicaltrials.gov/study/NCT07835360